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Summary. The distribution of rnet-enkephalin in the cat 
and its rnodifications following the stirnulation by 
intravenous clonidine, was studied with indirect 
irnrnunocytochernical techniques. We observed a 
decrease in the irnrnunoreactivity of rnet-enkephalin 
following the adrninistration of clonidine, relative to the 
controls, in the following structures: locus coeruleus, 
nucleus cuneforrnis, forrnatio reticularis, nucleus 
gigantocellularis, nucleus reticularis lateralis, nucleus 
reticularis, nucleus reticularis parvocellularis, nucleus 
sensorius superior n. trigernini, nucleus raphes, 
substantia grisea periventricularis, nucleus erninentiae 
teretis, colliculus inferior, nucleus rnotorius n. trigemini, 
nucleus tracto spinalis n. trigernini, tractus spinalis n. 
trigernini and nucleus tracto rnesencephalici n. trigernini. 
These experimental observations link the irnrnuno- 
reactivity changes to the structures that are associated 
with the direct action of clonidine and conclude that the 
pars rnetencephalinergicus of the efferent pontine 
pathway of pain is in rnorpho-functional relationship 
with the analgesia produced by clonidine; an analgesic 
of an endogenous opiate character. 
Key words: Met-enkephalin, Clonidine, Pons, Irnrnuno- 
cytochernistry, Cat 
lntroduction 
Modern neurobiology, solidly based on the neurona1 
doctrine (Ramón y Cajal, 1972), in the doctrine of 
synapses (Sherrington, 1920), in the concept of 
neurosecretion (Scharrer, 1928), in the functional 
classification of nerve fibres (Erlanger et al., 1926) and, 
in the whole body, the constantly-advancing doctrine of 
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intercellular cornrnunication substances (Lernbeck, 
1953; de Robertis, 1964; Bargrnan, 1968; Sirnon et al., 
1973; Terenius, 1973; Snyder and Sirnantov, 1977; 
Hokfett et al., 1980; Bloom, 1981) allows one to plan the 
therapeutic battle against pain on four fundamental 
fronts of the nervous systern: lst, the peripheral receptor; 
2nd, the anatomical pathways of nociception; 3rd, the 
synaptic regions with the neurotransrnitters and 
neurornodulators, and 4th, the cerebral cortex, the site of 
nociceptive integration. Convinced of the veracity of this 
quadruple plan-of-attack, the present experimental study 
was conducted to further the knowledge on the 2nd and 
3rd of these fronts at the leve1 of the pons of the cat. 
Met-enkephalin (Hughes et al., 1975) is  an 
endogenous pentapeptide opiate of the neurotransrnitter- 
neuromodulator class localized in the telencephalon, 
rnesencephalon, rhornbencephalon (locus coeruleus, 
forrnatio reticularis, nucleus raphes, etc.) and the spinal 
rnedulla (Sar et al., 1978; Kuber and Wilbur, 1980; 
Pickel et al., 1980; Glazer and Basbaurn, 1981; Haber 
and Else 1982; Sornogy et al., 1982; Bouras et al., 1984). 
In rnany different ways and specifically on the efferent 
nociceptor pathway (Glazer et al., 1981; Jessell, 1983; 
García Robles et al., 1988) it has, arnong severa1 other 
functions, that of acting on the presynaptic opiate 
receptors of the nociceptor pathway inhibiting the 
release of substance P (von Euler and Gaddurn, 1931) in 
the spinal rnedulla (Vacca-Galloway et al., 1985) and at 
other sites of the central nervous systern (Vázquez and 
Mufioz, 1989; Vázquez et al., 1990, 1993, 1995). The 
enkephalins control the transrnission of the nociceptor 
inforrnation inhibiting the release of substance P (Jessell 
and Iversen, 1977; Luque, 1988; Vázquez et al., 1993). 
Clonidine, an irnidazole derivative synthesised originally 
by Boehringer Ingelheirn in 1962 (Hoefke and Kobinger, 
1966), acts as a partial agonist of the a-2-adrenergic 
receptors and possesses clear hypotensive and analgesic 
effects (Schrnitt et al., 1974; Eisenbach et al., 1987; Max 
et al., 1988) as well as being efficacious in the treatrnent 
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of opiate withdrawal syndrome. To date, knowledge of 
the precise mechanisrn of the analgesic action is 
uncertain but it is thought that the endogenous opiates 
are implicated (Paalzon and Paalzon, 1976; Aghajanian, 
1978; Fielding et al., 1978; Gold et al., 1978; Lavarly 
and Roth, 1980;  Thoolen et a l . ,  1981) by local 
stirnulation of their release (Yaksh and Reddy, 1981; 
Goldstein, 1983; Yaksh, 1985; Nakamura and Ferreira, 
1988) or by action on substance P (Kuraishi et al., 1985). 
We propose that clonidine produces analgesia by release 
of rnet-enkephalin in the sites of the efferent pathway of 
pain. 
Indirect irnmunocytochemistry (Coons et al., 1942; 
Sternberger, 1979; Florez et al., 1987) is a suitable 
technique for evaluating the imrnunoreactive changes in 
met-enkephalin at the tissue leve1 (Nakane and Pierce, 
1966) since it facilitates direct comparison of cases and 
controls. The basis of our hypothesis is that, under the 
action of clonidine, a decrease in rnet-enkephalin would 
certainly be indicative of an increased transport and 
release of the pentapeptide into the synaptic spaces and, 
as such, that this present experimental study constitutes a 
further contribution to the knowledge of the anatomy of 
pain, particularly of its efferent discharge arm (Vázquez 
et al., 1995), and to the neurohistochemical basis of the 
analgesic action of intravenously-adminis tered 
clonidine. 
Materials and methods 
Experimental procedure 
We used 12 adult cats (2.5-4 Kg) divided into two 
groups: controls (4 cats) and experimental (8 cats). Al1 
the animals were anaesthetised with ketamine (40 
mg/Kg body weight) (Conrath-Verrier et al., 1983, 1986; 
Conrath-Verrier, 1984). Clonidine (1 dose of 15 rng/Kg 
diluted in 5 rnl of physiologic saline) was injected 
slowly via the saphena magna vein. Time lapses between 
ketarnine and clonidine adrninistrations and between 
clonidine and perfusion-sacrifice were 5 and 30 minutes, 
respectively. 
Tissue processing 
Animals of both groups were perfused with buffer 
(500 rnl) and then with 4% paraforrnaldehyde diluted in 
Sorensen buffer (Paese, 1962). The encephalon was 
obtained and postfixed in the sarne fixative for 12 h and 
then rinsed in severa1 baths of saccharose in Sorensen 
buffer. After washing, the encephalon was frozen in 
liquid nitrogen and 80 p m  axial transverse sections were 
obtained in a cryostat. 
al., 1986). Tissue sections were irnmersed in 0.3% H202 
in rnethanol to eliminate endogenous peroxidase and, 
after hydration, incubated with 1% normal sheep serum 
in 0.3% triton X-100. Sections were then incubated 
overnight with rabbit anti-met-enkephalin antibody 
(1:1600, Cambridge Research Biochemicals, Carnbridge, 
UK). Sheep anti-rabbit IgG horseradish peroxidase- 
conjugated antibodies at a dilution of 1:250 were used as 
secondary layer. Peroxidase was visualised with 3,3'- 
diarninobenzidine (DAB) and H 2 0 2  The following 
controls were used: a) pre-absorption of the first 
antibody with met-enkephalin; b) omission of the 
different antibodies; and c) exclusive treatment with 
DAB. Mapping was carried out according to the 
stereotaxic atlas of Snider and Niemer (1961). 
Results 
The results obtained are sumrnarised in Table 1 and 
those corresponding to the P3.5 sectional plane are 
partially illustrated in Fig. 1 .  The most irnportant 
findings were the following: 
In the control group: intense imrnunoreactivity in 
colliculus inferior, nucleus cuneiformis, locus coerulus 
and substantia grisea periventricularis; moderate 
immunoreactivity in formatio reticularis, nucleus 
rnotorius n. trigemini, nucleus tr. spinalis n. trigernini, 
nucleus reticularis gigantocellularis, nucleus reticularis 
lateralis, nucleus reticularis parvocellularis, nucleus 
sensorius superior n. trigemini and nucleus tr. mesence- 
phalicis n. trigernini; very slight imrnunoreactivity in 
nucleus tr. spinalis n. trigemini; and negative immuno- 
reactivity in tractus spinalis n. trigernini. 
In the treated group: rnoderate irnmunoreactivity in 
colliculus inferior, locus coerulus and substantia grisea 
periventricularis; slight imrnunoreactivity in nucleus 
cuneformis, forrnatio reticularis, nucleus rnotorius n. 
trigernini, nucleus reticularis parvocellularis, nucleus 
sensorius superior n. trigernini and nucleus tr. mesence- 
phalici n. trigernini; very slight imrnunoreactivity in 
nucleus tr. spinalis n. trigemini; and negative irnmuno- 
reactivity in tractus spinalis n. trigernini. 
In surnrnary, following the intravenous adrninis- 
tration of clonidine, we observed a decrease in rnet- 
enkephalin irnmunoreactivity in the colliculus inferior, 
nucleus cuneformis, formatio reticularis, locus coeruleus 
(Fig. 2), nucleus rnotorius n. trigemini, nucleus tr. 
spinalis n. trigernini, nucleus reticularis giganto- 
cellularis, nucleus reticularis lateralis, nucleus reticularis 
parvocellularis, nucleus sensorious superior n. trigemini, 
substantia grisae periventricularis, nucleus tractus 
rnesencephalici n .  trigemini and the absence or 




For the imrnunocytochernical detection of rnet- 
enkephalin, indirect techniques were used (Nakane and 
, Pierce, 1966; Falini and Taylor, 1983; Conrath-Verrier et 
In our study, the rnost important observations overall 
were of intense imrnunoreactivity in the rnesencephalon 
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in col l iculus  inferior, nucleus cuneformis,  locus nucleus sensorius superior n. trigemini and nucleus tr. 
coeruleus and substantia grisea periventricularis; mesencephalici n. trigemini; and slight immunoreactivity 
moderate immunoreactivity in formatio reticularis, in tractus spinalis n. trigemini. Following the intra- 
nucleus reticularis gigantocellularis, nucleus reticularis venous administration of clonidine, the intensity of 
parvocellularis, nucleus reticularis lateralis, nucleus immunoreactivity diminished in al1 of the pontine 
motorius n. trigemini, nucleus tr. spinalis n. trigemini, structures from intense to moderate, from moderate to 
Table 1. Summary of the immunoreactivity of met-enkephalin 
P2 P2.5 P3 P3.5 P4 P5 P6 P7 
Con Clo Con Clo Con Clo Con Clo Con Clo Con Clo Con Clo Con Clo 
-- 
Cin ++++ ++ ++++ ++ ++++ +++ O O O O O O O O O O 
Cu ++++ ++ ++++ ++ o o o O o o o o O o o O 
DU ++++ ++ ++ + O O O O O O O O O O O O 
FR +++ ++ +++ ++ ++++ ++ +++ ++ ++ ++ +++ + +++ ++ O O 
LDt - O O o o o o o O o o O O o 
L1 v + ++ - +++ ++ o o o o O o o o o o 
Ped M m - - - - - - o o o o 
Peds +++ + +++ + +++ +++ ++ +++ +++ - - - - - - 
PL + + O o O o o O o o o o o o o o 
PM O O O O O O O O O O O O O O 
RA ++ ++ ++ ++ ++ O O ++ ++ +++ ++ ++ +++ +++ ++ 
SGPV ++++ ++ ++++ +++ ++++ +++ ++ + - O O O O O O O 
TP + + + + + + + + + + + + + + O O 
BcM O O +++ ++ A++ +++ ++ + - O O O O O O O 
CTR O O - - - - - O O O O O O O 
CT Rp O O - - - - - - - - - - - - - - 
FLM O O - O O O O O O O O O O O O O 
TMtr O O +++ ++ +++ ++ +++ ++ O O O O O O O O 
LC o o o o ++++ +++ ++++ +++ o o o o o o o o 
Rgc o o o o - - - - - - +++ +++ 
TSr O O O O ++++ +++ +++ ++ ++ + O O O O O O 
MT O O O O O O + + +++ ++ +++ ++ O O O O 
OSM O O O O O O + + + - + - + - O O 
RPV o o o o o o - - - O o O o +++ ++ 
SST O O O O O O + + ++ + +++ +++ O O O O 
TRI O O O O O O - O O ++ ++ O O O O 
CPT O O O O O O O O - - - - - - - 
vi O o O o o o ++ + o o o o o o o O 
VM o o o o o o o o +++ ++ +++ ++ - - - 
VS o o o O O O o O ++ + o o o o O o 
RL O O O O O O O O O O O O O O +++ ++ 
Osl O o o O o o O o o O + - + - O O 
TD O O O O O O O O O O O O O O O O 
F O o o o o O O o O o ++ - - - o o 
VL o o O O O O o O o O +++ +++ - - - 
Abd o o o O o O o O o o o O o O O O 
Emt o o O o O o O o o o O O +++ +++ o O 
NEt o o o o o o O o O o o o +++ +++ +++ + 
NNA O O O O O O O O O O O O O +++ ++ + 
TEt o O o O o o o o o o O O ++ - + - 
GNF O O O O O O O O O O O O O O + + 
NF O O O O O O O O O O O O O O ++++ + 
Ph O o o o o o O o O o o O O O +++ ++ 
Cin: colliculus inferior; Cu: nucleus cuneiformis; DU: nucleus dorsalis lemnisci lateralis; FR: formatio reticularis; LDt: nucleus iatero dorsalis tegmentii; 
UV: nudeus ventralis lemnisci lateralis; PedM: pedunculus cerebellaris medius; PedS: pedunculus cerebellaris superior; PL: nudeus pontis lateralis; 
PM: nucleus pontis medialis; RA: nucleus raphes; SGPV: substantia grisea periventriwlaris; TP: tractus piramidalis; BcM: marginal nucleus of the 
brachium conjuntivum; QR: nucleus corporis trapezoidei; CtRp: corpus trapezoideum; FLM: fasciculus longihidinalis medialis; TMtr: nucleus tr. 
mesencephalici n. trigemini; LC: locus coeruleus; Rgc: nucleus reticularis gigantocellularis; Tsr: tractus spinocerebellaris ventralis; MT: nucleus 
motorius n. trigemini; OSM: nucleus olivaris superior medialis; RpV: nucleus reticularis parvocellularis; SSt: nucleus sensorius superior n. trigemini; 
TRi: nervus trigeminus; CR, corpus pontobulbare; Vi: nucleus vestibullaris inferior; Vm: nucleus vestibullaris medialis; Vs: nucleus vestibullaris 
superior; RL:' nucleus reticularis lateralis; Osl: nucleus olivaris superior lateralis; TD: nucleus tegmentalis dorsalis; F: nervus facialis; VL: nucleus 
vestibularis lateralis; Abd: nervus abducens; Ernt: nucleus eminentae teretis; NEt nucleus tr. spinalis n. trigemini; NNA: nucleus n. abducentis; 
TEt: tractus spinalis n. trigemini; GNF: genu n. facialis; NF: nucleus n. facialis; Ph: nucleus praepositus hypogl. lntensiiy of staining: -, negative; +, very 
low; ++, low; +++, moderate; ++++, intense; +++++, very intense; 0, this structure is not present at this site. 
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slight and from slight to negative, as shown in Table 1. 
This relates directly with the axonal transport and 
subsequent release of met-enkephalin into the synaptic 
space caused by the stimulus exercised by clonidine in 
the met-enkephalinergic system of the pons of the cat. 
We think that al1 of these structures are in morpho- 
functional relationship with the analgesia produced by 
clonidine as observed in clinical practice and in 
consequence, and that taking into account its place 
within the pain pathway (Oliveras et al., 1975; Proudpit 
and Anderson, 1975; Oleson et al., 1976; Pérez Casas 
and Bengoechea, 1977; Gonzalo, 1979; Florez and 
Martínez Lage, 1983), the efferent (analgesic) the arm of 
the pars met-enkephalinergica is linked into the overall 
arc of pain. Conversely, any met-enkephalinergic 
structure that, following the intravenous administration 
of clonidine, does not undergo modification in its grade 
of imrnunoreactivity, is not in functional relationship 
with the analgesia and, hence, must be associated with 
some other of the multiple functions of the pentapeptide 
(Fredrickson and Geary, 1982; Sitaram and Gillin, 1982; 
Akil et al., 1984; Arilla et al., 1986). We confirm, in 
view of the immunohistochemical data, the endo-genous 
opiate nature of the analgesic action of clonidine. Our 
previous studies using low-frequency electro- 
acupuncture confirm the analgesic action of endogenous 
opiates at the level of the met-enkephalinergic structures; 
a decrease in the immunoreactivity of met-enkephalin 
(Valseca, 1987) and, at the level of peptidergic system 
(substance P), a clear increase in the immunoreactivity 
(Moreno, 1988). Al1 these contribute to the linking of the 
structures studied to the anatomy of pain and, as such, 
confirm the role of pontine substance P following the 
administration of clonidine. This demonstrates that in the 
asta vosterior of the cervical medulla of the cat. 
follo6ing the intrarachidial administration of clonidine; 
substance P increases its immunoreactivitv (Rubio. 
1992) and is released in blocks (Kuraishi et al.; 1985): 
Terminal and collateral route connections exist among 
the afferent spinoreticular and spino reticulo 
mesencephalenergic nociceptors (Mehler et al., 1960; 
Levante and Abel-Fessard, 1972; Kerr, 1975; Pearl and 
Anderson, 1976; Glazer and Basbaum, 1981) and with 
the formatio reticular troncoencephalica. Based on the 
immunoreactivity changes that relate to the structural 
modifications in the different nuclei trigemini which are 
understood to be activated by pontine formatio 
reticularis and the substantia grisea periventricular, we 
propose the existence of met-enkephalinergic reticulo- 
trigeminal fibre modulators of cephalic pain in parallel 
with the known reticulospinal modulators of somato- 
visceral pain (Shetter and Atkinson, 1977; Nieuwenhuys 
et al., 1979). The locus coeruleus is a centre for the 
noradrenergic-met-enkephalinergic interaction that, 
following the co-transmission concept of Hokfelt 
(iiokfelt et al., 1980), now seems to be an important site 
of the efferent arm of the pain pathway at the pontine 
level and in which, possibly, met-enkephalin acts as a 
modulator of the release of noradrenalin in the synaptic 
space (Aghajanian, 1978), acting on the pre-synaptic 
opiate receptors, blocking the release of the neuro- 
transmitter exciters of the noradrenalin type and of 
substance P. Clonidine inhibits the neurona1 activity of 
the locus coeruleus (Svenson et al., 1975). 
Finally, based on the immunohistochemical data of 
our present study and that of other studies, we 
hypothesise and propose, albeit with caution, the 
involvement of the following morphostructures in the 
Flg. 1. Representation of met- 
enkephalin immunoreactivity. 
The results obtained in the 
control animals are shown on 
the right and those in the 
experimental group on the 
left. The increasing brown 
intensity indicates five levels 
of immunoreactivity: very 
weak, weak, moderate, 
intense and very intense. 
Control: very weak (Mt, Osm, 
Sst, TP); moderate (Bcm, 
TMtr, Tsr, PedS); intense (Lc). 
Experimental: very weak (Mt, 
Osm, Sst, TP); weak (Bcm, 
PedS, TMtr, Tsr); moderate 
(Lc). 
Met-enkephalin, pons and clonidine 
efferent (analgesic) arm of the arc encompassing the 
anatomy of pain: septal area, with the nucleus lateralis, 
medialis and acumbens (Cáceres, 1991; Vázquez et al., 
1995); pars met-enkephalinergica of media1 forebrain 
bundle (Vázquez et al., 1995); the habenula and pars 
met-enkephalinergica of habenulointerpeduncular bundle 
or the retroreflective bundle of Meyner (Muñoz, 1986; 
Vázquez et al., 1990); the nucleus interpeduncularis 
(Fernández, 1989; Vázquez et al., 1995); the substantia 
grisea periaqueductal (Reynolds, 1969; Fernández, 
1989); the formatio reticularis (García, 1991); colliculus 
inferior; nucleus of raphe; nucleus cuneiformis of 
Olszewski; locus coeruleus; and nucleus and structures 
dependent on the trigemini activated by the met- 
enkephalinergic reticulotrigeminal fibres. The rafe-spinal 
system (Pérez Casas and Bengoechea, 1977; Gonzalo, 
1979) that, via the funiculus dorsolateralis connection 
with the posterior horn of the medulla, activate the met- 
enkephalinergic interneurones of the 1, 11 and V laminae 
of Rexel that inhibit, possibly pre-synaptically, the 
Fig. 2. Locus coenileus. 
A. Control group: iritense 
immuno~ctlviiy. B. Clonidine 
(experimental) group: moderate 
immunoreacthri. x 100 
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primary afferent nociceptors by blocking the release of 
substance P. 
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